Published On: Wed, Oct 19th, 2016

Mednax, Inc (NYSE:MD) Updated Analyst Coverage


A number of investment brokers have recently updated their price targets on shares of Mednax, Inc (NYSE:MD).

Most recent broker ratings

09/20/2016 – Mednax, Inc had its “buy” rating reiterated by analysts at Mizuho. They now have a USD 79 price target on the stock.

03/14/2016 – Mednax, Inc had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 76 price target on the stock.

03/08/2016 – Mednax, Inc had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 76 price target on the stock.

03/07/2016 – Mednax, Inc had its “neutral” rating reiterated by analysts at Susquehanna. They now have a USD 70 price target on the stock.

12/02/2015 – Mednax, Inc had its “equal weight” rating reiterated by analysts at Stephens. They now have a USD 77 price target on the stock.

11/30/2015 – Mednax, Inc had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 88 price target on the stock.

10/02/2015 – Citigroup began new coverage on Mednax, Inc giving the company a “neutral” rating.

09/16/2015 – JP Morgan began new coverage on Mednax, Inc giving the company a “overweight” rating. They now have a USD 94 price target on the stock.

07/31/2015 – Mednax, Inc had its “buy” rating reiterated by analysts at Dougherty & Co. They now have a USD 90 price target on the stock.

05/20/2015 – Mednax, Inc had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 79 price target on the stock.

05/13/2015 – Mednax, Inc had its “outperform” rating reiterated by analysts at Raymond James. They now have a USD 80 price target on the stock.

10/09/2014 – Robert W. Baird began new coverage on Mednax, Inc giving the company a “outperform” rating. They now have a USD 62 price target on the stock.

09/16/2014 – SunTrust began new coverage on Mednax, Inc giving the company a “neutral” rating. They now have a USD 62 price target on the stock.

12/17/2013 – KeyBanc began new coverage on Mednax, Inc giving the company a “hold” rating.

The share price of Mednax, Inc (NYSE:MD) was up +2.10% during the last day of trading, with a day high of 67.18. 242298 shares were traded during the last session.

The stock’s 50 day moving average is 65.92 and its 200 day moving average is 68.40. The stock’s market capitalization is 6.17B. Mednax, Inc has a 52-week low of 61.40 and a 52-week high of 83.20.

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network is composed of affiliated physicians, including those providing neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It also has physicians providing anesthesia care. In addition, it has affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. The Company also provides teleradiology services in the United States and Puerto Rico through a network of affiliated radiologists. The Company also offers specialties, including pediatric ophthalmology, plastic surgery, pediatric urology, developmental pediatrics and radiology.